Life Sciences Chronicle
Ogan Gurel MD
Thinking about Life Sciences: Category Archive for Pharmaceuticals

A Pharmaceutical Addiction

FDA issues a "black box" warning for Avandia - A Balancing Act Between Safety and Choice

The Deconstruction of Amgen

Drug Safety & FDA Reform : An Audio (.mp3) Podcast

FDA panel votes to retain Avandia on the market: DrugWonks celebrate; Prince Hal rails against Falstaff ...

FDA Report on Avandia: Implications and a "critique" of the critique

Avandia, the Drug Safety Debate and How to Get a Nobel Prize

Patent Reform Act of 2007: Innovation, Implications and the American Inventor

Financial Incentives Can Drive New Pharmaceutical & Medical Technology Adoption: What are the Implications?

FDA Reform Redux: On Business Models, Regulatory Reform and Safety

FDA: Tortoise, Hare or Something Else

An Unfolding Tragedy: Balancing Act between Innovation and Access

Personalized Medicine and Technology Convergence: Decisive Trends

KKR Buys First Data: On Private Equity, Pipelines, Development

The Devil’s in the Details: A Closer Look at Merck’s Vioxx Trials

A Time to Make Friends: More Partnerships in Biotech, Med Tech?

Drug /Device Safety Debate to Yield Big Changes, Grow More Controversial

Perspective Following BIO 2006: The Midwest as Innovation Central?